Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|December 17, 2009
Anemia response and safety to epoetin-beta treatment in patients with neoadjuvant therapy prior to primary digestive tract tumor surgeryAntonio Gómez, Mercedes Salgado, Manuel Valladares-Ayerbes, et al.
Plos One|January 4, 2013
miR-203 regulates cell proliferation through its influence on Hakai expressionVanessa Abella, Manuel Valladares, Teresa Rodriguez, et al.
Molecular Cancer Therapeutics|December 14, 2011
New insights into molecular mechanisms of sunitinib-associated side effectsGuadalupe Aparicio-Gallego, Moisés Blanco, Angélica Figueroa, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 16, 2010
Efficacy of epoetin-beta 30,000 IU/week in correcting anaemia in patients with gastrointestinal tumours subjected to concomitant chemoradiotherapyAntonio Gómez, Mercedes Salgado, Manuel Valladares-Ayerbes, et al.
Expert Opinion on Biological Therapy|March 11, 2025
State of the art of the molecular hyperselection to guide treatment with anti-EGFR antibodies in RAS WT mCRC: implications for clinical practice and future perspectivesPilar García-Alfonso, Manuel Valladares-Ayerbes, Andrés J Muñoz Martín, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 19, 2008
Origin of renal cell carcinomasManuel Valladares Ayerbes, Guadalupe Aparicio Gallego, Silvia Díaz Prado, et al.
Journal of Cancer Research and Clinical Oncology|February 17, 2018
Author Correction: Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trialsJulien Taieb, Fernando Rivera, Salvatore Siena, et al.
Cancer Chemotherapy and Pharmacology|June 27, 2015
Current controversies in the management of metastatic colorectal cancerRuth Vera, Vicente Alonso, Javier Gállego, et al.
Journal of Cancer Research and Clinical Oncology|October 30, 2017
Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trialsJulien Taieb, Fernando Rivera, Salvatore Siena, et al.
Experimental and Molecular Pathology|July 6, 2010
Evaluation of COX-2, EGFR, and p53 as biomarkers of non-dysplastic oral leukoplakiasSilvia Maria Díaz Prado, José Luis López Cedrún, Ramón Luaces Rey, et al.
Pageof 7